Skip to main content
SpringerLink
Log in

Results of Chemotherapy of Malignant Brain Tumors in Adults

  • Chapter
Therapy of Malignant Brain Tumors

Abstract

The aim of this article is to review the results of modern chemotherapy and multiple agent trials in the treatment of malignant brain tumors in adults. As introduction a brief outline of diagnostic methods is given, and some remarks on time schedule and pecularities of follow-up examinations and treatment evaluation are made to allow a more critical appraisal of the clinical results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. I. Aabo K, Walbom-Jorgensen S (1986) Central nervous system complications by malignant lymphomas: Radiation schedule and treatment results. J Radiat Oncol Biol Phys 12: 197–202

    CAS  Google Scholar 

  2. Afra D, Lazar L, Slowik F (1979) Combined treatment of medulloblastomas in adults. In: Paoletti P, Walker MD, Butti G, Knerich R (eds) Multidisciplinary aspects of brain tumor therapy. Elsevier/North-Holland, pp 177–188

    Google Scholar 

  3. Allen JC, Bloom J, Ertel I, Evans A, Hammond D, Jones H, Levin V, Jenkin D, Sposto R, Wara W (1986) Brain tumors in children: Current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease. Semin Oncol 13: 110–122

    Google Scholar 

  4. Andersen AP (1981) Scandinavian glioblastoma study group: Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time. Cancer 47: 649

    PubMed  Google Scholar 

  5. Aroney RS, Kaplan RS, Salcman M, Montgomery E, Wiernik PH (1982) A phase II trial of AZQ (NSC 182986) in patients with recurrent primary or metastatic brain tumors. Abstract, ASCO Meeting

    Google Scholar 

  6. Aronin PA, Mahaley MS jr, Rudnick SA, Dudka L, Donohue JF, Selker RG, Moore P (1980) Prediction of BCNU pulmonary toxicity in patients with malignant gliomas. N Engl J Med 303: 183–188

    PubMed  CAS  Google Scholar 

  7. Ascherl GF, Hilal SK, Brisman R (1981) Computed tomography of disseminated meningeal and ependymal malignant neoplasms. Neurology 31: 567–574

    PubMed  Google Scholar 

  8. Barnett MJ, Ganesan TS, Waxman JH, Richards MA, Smith BF, Rohatiner AZS, Dhaliwal HS, Slevin ML, Lister TA (1985) Neurotoxicity of high-dose cytosine arabinoside. Prog Exp Tumor Res 29: 177–182

    PubMed  CAS  Google Scholar 

  9. Bateman DE, McDermott J, Hughes DR, Edwardson JA (1986) The selective release of polypeptides from human glioma cell cultures and their possible modification by dexamethasone. Abstract, International meeting on brain oncology, Rennes, p 11

    Google Scholar 

  10. Behnke J, Mach JP, Buchegger F, Carrel S, Delaloye B, de Tribolet N (1986) In vivo localization of radiolabelled monoclonal antibody in human gliomas. Abstract, International meeting on brain oncology, Rennes, p 22

    Google Scholar 

  11. Blasberg R, Patlak C (1979) Metastatic brain tumors: local blood flow and capillary permeability. Neurology 29: 547

    Google Scholar 

  12. Bleyer WA, Drake JC, Chabner BA (1973) Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med 289: 770–773

    PubMed  CAS  Google Scholar 

  13. Bleyer WA, Poplack DG, Simon RM (1978) “Concentration x Time” methotrexate via a subcutaneous reservoir: A less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood 51: 835–842

    Google Scholar 

  14. Bloom HJG (1982) Medulloblastoma in children: Increasing survival rates and further prospects. Int J Radiat Oncol Biol Phys 8: 2023–2027

    PubMed  CAS  Google Scholar 

  15. Boethius J, Blomgren H, Collins VP, Greitz T, Strander H (1983) The effect of systemic human interferon-alpha administration to patients with glioblastoma multiforme. Acta Neurochir (Wien) 68: 239–251

    CAS  Google Scholar 

  16. Boettcher HD, Wagner W, Haverkamp U, Schadel A (1983) Zum Auftreten and zur Prognose des Medulloblastoms im Erwachsenenalter. Strahlentherapie 159: 143–146

    Google Scholar 

  17. Bogdahn U, Bogdahn S, Mertens HG, Dommasch D, Wodarz R, Wünsch PH, Kühl P, Richter E (1986) Primary non-Hodgkin’s lymphomas of the CNS. Acta Neurol Scand 73: 602–614

    PubMed  CAS  Google Scholar 

  18. Brooks DJ, Beaney RP, Thomas DGT (1986) The role of positron emission tomography in the study of cerebral tumors. Semin Oncol 13: 83–93

    PubMed  CAS  Google Scholar 

  19. Brucher JM (1983) Stereotaxic biopsies of the brain. In: Krauseneck P, Mertens HG (Hrsg) Therapie maligner Neoplasien des Gehirns. Perimed, Erlangen, S 26–28

    Google Scholar 

  20. Bryan P (1974) CSF seeding of intra-cranial tumours: A study of 96 cases. Clin Radio! 25: 355–360

    CAS  Google Scholar 

  21. Budka H, Majdic, Knapp W (1985) Cross-reactivity between human hemopoietic cells and brain tumors as defined by monoclonal antibodies. J Neuro-Oncol 3: 173–179

    CAS  Google Scholar 

  22. Burger PC, Dubois PJ, Schold SC jr, Smith KR jr, Odom GL, Crafts DC, Giangaspero F (1983) Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58: 159–169

    PubMed  CAS  Google Scholar 

  23. Burger PC (1983) Pathologic anatomy and CT correlations in the glioblastoma multiforme. Appl Neurophysiol 46: 180–187

    PubMed  CAS  Google Scholar 

  24. Burger PC, Vogel FS, Green SB, Strike TA (1985) Glioblastoma multiforme and anaplastic astrocytoma. Cancer 56: 1106–1111

    PubMed  CAS  Google Scholar 

  25. Burger PC (1986) Malignant astrocytic neoplasms: Classification, pathologic anatomy, and response to treatment. Semin Oncol 13: 16–26

    PubMed  CAS  Google Scholar 

  26. Byar DP, Green SB, Strike TA (1983) Prognostic factors for malignant glioma. In: Walker MD (ed) Oncology of the nervous system. M Nijhoff, Boston, pp 379–396

    Google Scholar 

  27. Cairncross JG, Chernik NL, Kimm JH, Posner JB (1979) Sterilization of cerebral metastases by radiation therapy. Neurology 29: 1195–1202

    PubMed  CAS  Google Scholar 

  28. Cairncross JG, Posner JB (1983) The management of brain metastases. In: Walker MD (ed) Oncology of the nervous system. M Nijhoff, Boston, pp 341–378

    Google Scholar 

  29. Cascino TL, Byrne TN, Deck MDF, Posner JB (1983) Intraarterial BCNU in the treatment of metastatic brain tumors. J Neuro-Oncol 1: 211–218

    CAS  Google Scholar 

  30. Carey RW, Davis JM, Zervas NT (1981) Tamoxifen-induced regression of cerebral metastases in breast carcinoma. Cancer Treat Rep 65: 793–795

    PubMed  CAS  Google Scholar 

  31. Casimir M, Yap HY, di Stefano A, Hortobagyi GN, Blumenschein GR (1981) The influence of combined modality treatment on the survival of breast cancer patients with brain metastases. ASCO Abstracts, C-427

    Google Scholar 

  32. Chan PYM, Byfield JE, Campbell T, Sladoff L, Rao AR (1980) Combined chemotherapy and irradiation in the treatment of brain metastases from lung cancer. In: Weiss E, Gilbert HA, Posner JB (eds) Brain metastasis. Hall, Boston

    Google Scholar 

  33. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y (1983) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52: 997–1007

    PubMed  CAS  Google Scholar 

  34. Chatel M (1986) EORTC chemotherapeutic trials in malignant brain gliomas. Abstract 14th Int Cancer Congr, Budapest, p 294

    Google Scholar 

  35. Cohen ME, Duffner PK (1984) Brain tumors in children. Raven Press, New York

    Google Scholar 

  36. Colomer R, Fuentes R, Boada M, Rubio D (1986) Regression of brain metastases from breast cancer with tamoxifen. Abstr 14th Int Cancer Congr, Budapest, p 470

    Google Scholar 

  37. Conte PF, Guerrasio A, Bumma C, Giaccome C, Musella R, Lombard GF, Distefano FF, Calciati A (1982) VM 26, adriamycine and CCNU combination chemotherapy in metastatic brain tumours. In: Hildebrand D, Gangji D (eds) Treatment of neoplastic lesions of the nervous system. Pergamon Press, Oxford New York, pp 161–164

    Google Scholar 

  38. Curt GA, Schilsky R, Kelly J, Kufta C, Smith B, Thomas C, Young RC (1982) Phase II study of aziridinylbenzoquinone (AZQ) in high grade gliomas. Abstract, ASCO meeting

    Google Scholar 

  39. Darling JL, Bradley NJ, Pilkington GJ, Lantos PL, Thomas DGT (1984) Differential effects of human leukocyte (IFN-gamma) and fibroblast ( IFN-beta) derived interferons on human glioma cell cultures in vitro. Neuropathol Appl Neurobiol 10: 309

    Google Scholar 

  40. Decker DA, Sarraf MA, Kresge C, Austin D, Wilner HI (1985) Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. J Neuro-Oncol 3: 19–21

    CAS  Google Scholar 

  41. Di Chiro G (1985) Brain imaging of glucose utilization in cerebral tumors. In: Sokoloff L (ed) Brain imaging and brain function. Raven Press, New York, pp 185–197

    Google Scholar 

  42. Djerassi I, Kim JS, Reggev A (1985) Response of astrocytoma to high-dose methotrexate with citrovorum factor rescue. Cancer 55: 2741–2747

    PubMed  CAS  Google Scholar 

  43. Dommasch D, Przuntek H, Grüninger W, Mertens HG (1976) Intrathecal cytostatic chemotherapy of meningitis carcinomatosa. Eur Neurol 14: 178

    PubMed  CAS  Google Scholar 

  44. Donoso JA, Samson F (1984) Mechanisms of neurotoxicity of anticancer drugs. In: Blum K, Manzo L (eds) Neurotoxicology. Marcel Dekker, New York Basel

    Google Scholar 

  45. Duff TA, Borden E, Bay J, Phepmeier J, Sielaff K (1986) Phase II trial of interferon-I3 for treatment of recurrent glioblastoma multiforme. J Neurosurg 64: 408–413

    PubMed  CAS  Google Scholar 

  46. Ehya H, Hajdu SI, Melamed MR (1981) Cytopathology of non lymphoreticular neoplasms metastatic to the central nervous system. Acta Cytol 25 /6: 599–610

    PubMed  CAS  Google Scholar 

  47. E.O.R.T.C. Brain Tumor Group (1976) Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—first evaluation. Eur J Cancer 12: 41–45

    Google Scholar 

  48. E.O.R.T.C. Brain Tumor Group (1978) Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—final evaluation. Eur J Cancer 14: 851–856

    Google Scholar 

  49. E.O.R.T.C. Brain Tumor Group (1980) Effect of DDMP (2, 4-diamino-5–3’, 4’dichlorophenyl-6-methylpyrimidine) on brain tumors. A phase II study. Europ J Cancer 16: 1639–1640

    Google Scholar 

  50. E.O.R.T.C. Brain Tumor Group (1981) Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. J Neurosurg 55: 27–31

    Google Scholar 

  51. E.O. R.T.C. Brain Tumor Group (1983) Aberle HG, Brotchi J, Lemaire M, Calliauw L, Chatel M, de Barsy T, Longueville J, de Tribolet N, Bernasconi S, Garfield J, Punt J, Gonzales D, Greiner R, Haefliger LM, Haferkamp G, Hery M, Hildebrand J, Regnier R, Resche F, Bourdin S, Dalesio O, Solbu G: Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: A randomized double-blind study. Eur J Cancer Clin Oncol 19 /1: 39–42

    Google Scholar 

  52. E.O.R.T.C. (1985) Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1aziridinyl)-3,6-dioxodiethylester) in recurring supratentorial malignant brain gliomas—a phase II study. Eur J Cancer Clin Oncol 21 /1: 143–146

    Google Scholar 

  53. Erlich SS, Davis RL (1978) Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme. Cancer 42: 2854–2864

    PubMed  CAS  Google Scholar 

  54. Ettinger LJ, Freeman AI, Creaven PJ (1978) Intrathecal methotrexate overdose without neurotoxicity. Cancer 41: 1270–1273

    PubMed  CAS  Google Scholar 

  55. Ettinger LJ (1982) Phannacokinetics and biochemical effects of a fatal intrathecal methotrexate overdose. Cancer 50: 440–450

    Google Scholar 

  56. Eyre HJ, Sause WT (1985) Treatment of meningeal carcinomatosis with irradiation plus intrathecal methotrexate: A Southern Oncology Group study, ASCO Proc 4: 149

    Google Scholar 

  57. Feun LG, Stewart DJ, Maor M, Leavens ME, Savaraj N, Burgess MA, Yung WKA, Benjamin RS (1983) A pilot study of cisdiamminedichloroplatinum and radiation therapy in patients with high grade astrocytomas. J Neuro-Oncol 1: 109–113

    CAS  Google Scholar 

  58. Feun LG, Yung WKA, Leavens ME. Burgess MA, Obbens EA, Bedikian AY, Savaraj N, Stewart DJ, Benjamin RS, Fields WS, Bodey GP (1984) A phase II trial of 2,4,diaziridinyl 3,6-bis(carboethoxy amino)1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors. J Neuro-Oncol 2: 13–17

    CAS  Google Scholar 

  59. Feun LG, Wallace S, Stewart DJ, Chuang VP, Yung WKA, Leavens ME, Burgess MA, Savaraj N, Benjamin RS, Young SE, Tang RA, Handel S, Mavligit G, Fields WS (1984) Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 54: 794–799

    PubMed  CAS  Google Scholar 

  60. Fewer D, Wilson CB, Boldrey EB, Enot KJ, Powell MR (1972) The chemotherapy of brain tumors. Clinical experience with carmustine (BCNU) and vincristine. JAMA 222 /5: 549–552

    PubMed  CAS  Google Scholar 

  61. Friedman HS, Schold SC jr (1985) Rational approaches to the chemotherapy of medulloblastoma. Neurol Clin 3: 843–853

    PubMed  CAS  Google Scholar 

  62. Friedman HS, Schold SC jr (1985) Rational approaches to the chemotherapy of medulloblastoma. Neurol Clin 3: 843–853

    PubMed  CAS  Google Scholar 

  63. Fulton DS, Levin VA, Gutin PH, Edwards MSB, Seager ML, Stewart J, Wilson B (1982) Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors. Cancer Chemother Pharmacol 8: 285291

    Google Scholar 

  64. Galicich JH, Sundaresan N, Thaler HT (1980) Surgical treatment of single brain metastasis. Evaluation of results by computerized tomography scanning. J Neurosurg 53: 63–67

    Google Scholar 

  65. Gastaut JA, Grisoli F, Vincentelli F, Peragut JC, Maraninchi D, Andrac L, Carcassonne Y (1982) Intracranial malignant lymphoma. In: Hildebrand D, Gangji D (eds) Treatment of neoplastic lesions of the nervous system. Pergamon Press, Oxford New York, pp 149–155

    Google Scholar 

  66. Gehan EA, Walker MD (1977) Prognostic factors for patients with brain tumors. Natl Cancer Inst Monogr 46: 189–195

    PubMed  CAS  Google Scholar 

  67. Gerosa MA, di Stefano E, Olivi A (1981) VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: Preliminary report. Surg Neurol 15 /2: 128–134

    PubMed  CAS  Google Scholar 

  68. Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E jr, Batzdorf U, Brooks WH, Hunt WE, Mealey J jr, Odom GL, Paoletti P, Ransohoff J II, Robertson JT, Selker RG, Shapiro WR, Smith KR jr, Wilson CB, Strike T (1983) Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67/2: 123132

    Google Scholar 

  69. Green SB, Byar DP, Strike TA, Alexander E jr, Brooks WH, Burger PC, Hunt WE, Mealey J jr, Odom GL, Paoletti P, Pistenmaa DA, Ransohoff J II, Robertson JT, Selker RG, Shapiro WR, Smith KR jr (1984) Randomized comparisons of BCNU, streptozotocin, radiosensitizer, and fractionation of radiotherapy in the postoperative treatment of malignant glioma (study 7702). ASCO Proc 3: 260

    Google Scholar 

  70. Green SB, Byar DB, Strike TA, Burger PC, Mahaley MS, Mealey J jr, Pistenmaa DA, Ransohoff J II, Robertson JT, Selker RG, Shapiro WR, VanGilder JC (1985) Randomized phase II comparison of PCNU and AZQ for the treatment of primary brain tumors (study 8120). ASCO Proc 4: 143

    Google Scholar 

  71. Grisold W, Weiss R, Jellinger K (1984) Klinik and zytologische Diagnostik der meningealen Neoplasien. In: Heyden HW von, Krauseneck P (Hrsg) Hirnmetastasen. Zuckschwerdt, München Bern Wien (Aktuelle Onkol 13, S 85–103 )

    Google Scholar 

  72. Groothuis DR, Molnar P, Blasberg RG (1984) Regional blood flow and blood-totissue transport in five brain tumor models. Implications for chemotherapy. In: Brain tumor biology. Karger, Basel, pp 32–153 (Prog Exp Tumor Res, vol 24)

    Google Scholar 

  73. Gutin PH, Wilson CB, Kumar ARV, Boldrey EB, Levin V, Powell M, Enot KJ (1975) Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors. Cancer 35: 1398–1404

    Google Scholar 

  74. Haid M, Khandekar JD, Christ M (1985) Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. Cancer 56: 1311–1315

    PubMed  CAS  Google Scholar 

  75. Hande KR, Stein RD, Mcdonough DA, Greco FA, Wolff SN (1982) Effects of high-dose cytarabine. Clin Pharmacol and Therapeutics 31 /5: 669–674

    CAS  Google Scholar 

  76. Hanson B, Malarme M, Abele R, Regnier R, Hildebrand J (1982) Treatment results in neoplastic meningitis. In: Hildebrand J, Gangji D (eds) Treatment of neoplastic lesions of the nervous system. Pergamon Press, Oxford New York, pp 59–61

    Google Scholar 

  77. Hatlevoll R, Lindegaard KF, Hagen S. Kristiansen K, et al. (1985) Combined modality treatment of operated astrocytomas grade 3 and 4. Cancer 56: 41–47

    PubMed  CAS  Google Scholar 

  78. Helle TL, Britt RH, Colby TV (1984) Primary lymphoma of the central nervous system. J Neurosurg 60: 94–103

    PubMed  CAS  Google Scholar 

  79. Herbst KD, Corder MP, Justice GR (1976) Successful therapy with methotrexate of a multicentric mixed lymphoma of the central nervous system. Cancer 38: 1476–1478

    PubMed  CAS  Google Scholar 

  80. Heyden HW von, Krauseneck P (Hrsg) (1984) Hirnmetastasen. Zuckschwerdt, München Bern Wien (Aktuelle Onkologie 13 )

    Google Scholar 

  81. Hildebrand J, Brihaye JM, Wagenknecht L, Michel J, Kenis Y (1975) Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors. Eur J Cancer 11: 585–587

    PubMed  CAS  Google Scholar 

  82. Hildebrand J, Brihaye J, Wagenknecht JM, Kenis Y (1975) Combination therapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors. Eur J Cancer 11: 585–587

    PubMed  CAS  Google Scholar 

  83. a. Hildebrand J, Gangji D (eds) (1982) Treatment of neoplastic lesions of the nervous system. Pergamon Press, Oxford New York

    Google Scholar 

  84. Hildebrand J (1985) Current status of chemotherapy of brain tumours. Prog Exp Tumor Res 29: 152–166

    PubMed  CAS  Google Scholar 

  85. Hirakawa K, Ueda S, Nakagawa Y, Suzuki K, Fukuma S, Kita M, Imanishi J, Kishida T (1983) Effect of human leukocyte interferon on malignant brain tumors. Cancer 51 /11: 1976–1981

    PubMed  CAS  Google Scholar 

  86. Hochberg FH, Miller G, Schooley RT, et al. (1983) CNS lymphoma related to Epstein-Barr virus. N Engl J Med 309: 745–749

    Google Scholar 

  87. Jellinger K, Vole D, Grisold W, Flament H, Vollmer R, Weiss R (1983) Kombinationsbehandlung maligner Gliome. Wien klin Wschr 95 /12: 407–416

    PubMed  CAS  Google Scholar 

  88. Jellinger K (1983) Histologische Klassifikation und therapiebedingte Veränderungen. In: Krauseneck P, Mertens HG (Hrsg) Therapie maligner Neoplasien des Gehirns. Perimed, Erlangen, S 15–25

    Google Scholar 

  89. Jellinger K (1983) Pathologic effects of chemotherapy. In: Walker MD (ed) Oncology of the nervous system. M Nijhoff, Boston, pp 285–340

    Google Scholar 

  90. Jellinger K (1984) Häufigkeit und Charakteristik der zerebralen Karzinommetastasen. In: Heyden HW von, Krauseneck P (HTsg) Hirnmetastasen. Zuckschwerdt, München Bern Wien (Aktuelle Onkologie 13, S 49–79 )

    Google Scholar 

  91. Jellinger K (1986) Present limits of conventional treatment for malignant brain tumors. In: Hatanaka H (ed) Boron-neutron capture therapy for tumors. Nishimura, Tokyo, pp 309–349

    Google Scholar 

  92. Jellinger K (1986) Present limits of conventional treatment for malignant brain tumors. In: Hatanaka H (ed) Boron-neutron capture therapy for tumors. Nishimura, Tokyo, pp 309–349

    Google Scholar 

  93. Jenkin RDT, Simpson WJK, Keen CW (1978) Pineal and suprasellar germinomas. J Neurosurg 48: 99–107

    PubMed  CAS  Google Scholar 

  94. Kaplan RS, Wiernik PH (1984) Neurotoxicity of antitumor agents. In: Perry MC (ed) Toxicity of chemotherapy. Grune & Stratton, London, pp 365–433

    Google Scholar 

  95. Kessinger A, Lemon HM, Foley JF (1979) VM-26 as a second drug in the treatment of brain gliomas. Cancer Treat Rep 63: 511–512

    PubMed  CAS  Google Scholar 

  96. Krauseneck P, Mertens HG (Hrsg) (1983) Therapie maligner Neoplasien des Gehirns. Perimed, Erlangen

    Google Scholar 

  97. Krauseneck, P (1984) Chemotherapie von Hirnmetastasen. In: Heyden HW von, Krauseneck P (Hrsg) Hirnmetastasen. Zuckschwerdt, München Bern Wien. ( Aktuelle Onkologie 13, S 167–179 )

    Google Scholar 

  98. Krauseneck P, Mertens HG, Richter E, Schmidt M, Halves E, Bogdahn U, Kappos L, Seybold D (1985) Combined chemotherapy of inoperable and operable malignant gliomas. In: Voth D, Krauseneck P (eds) Chemotherapy of gliomas. De Gruyter, Berlin New York, pp 353–359

    Google Scholar 

  99. Krauseneck P, Seybold D, Mertens HG (1985) Pseudo-recurrence in malignant brain tumors. In: Voth D, Krauseneck P (eds) Chemotherapy of gliomas. De Gruyter, Berlin New York, pp 283–290

    Google Scholar 

  100. Krauseneck P, Dommasch D, Dienst P, Bogdahn U, Kappos L, Seybold D, Mertens HG (1985) Intrathekale Verträglichkeit von Cytosin-Arabinosid. Verh Dt Ges Neur 3: 500–504

    Google Scholar 

  101. Krauseneck P, Richter E, Dittmann W, Müller HA, Ködel B, Bogdahn U (1986) Radiotherapy in low grade gliomas. Abstr Int Meeting on Brain Oncology, Rennes, p 50

    Google Scholar 

  102. Kumar ARV, Renaudin J, Wilson CB, Boldrey EB, Enot KJ, Levin VA (1974) Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study. J Neurosurg 40: 365–371

    Google Scholar 

  103. Kunze P, Hoppe W, Riedel C, Döge H (1980) Primäres malignes Lymphom des Zentralnervensystems. Psychiat Neurol Med Psychol 32: 373–381

    PubMed  CAS  Google Scholar 

  104. Lee Y, Bigner DD (1985) Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas. Neurol Clin 3: 901–917

    PubMed  CAS  Google Scholar 

  105. Letendre L, Banks PM, Reese DF, Mill RH, Scanlon PW, Kiely JM (1982) Primary lymphoma of the central nervous system. Cancer 49: 939–943

    PubMed  CAS  Google Scholar 

  106. Levin VA, Crafts D, Wilson CB, Kabra P, Hansch C, Boldrey E, Enot J, Neely M (1975) Imidazole carboxamides: Relationship of lipophilicity to activity against intracerebral murine glioma 26 and preliminary phase II clinical trial of 5-[3,3-bis(2chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in primary and secondary brain tumors. Cancer Chemo Rep 59 /2: 327–331

    CAS  Google Scholar 

  107. Levin VA, Crafts DC, Wilson CB, et al. (1976) BCNU and procarbazine treatment for malignant brain tumors. Cancer Treat Rep 60: 243

    PubMed  CAS  Google Scholar 

  108. Levin VA, Hoffman WF, Pischer TL, Seager ML, Boldrey EB, Wilson CB (1978) BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors. Cancer Treat Rep 62 /12: 2071–2076

    PubMed  CAS  Google Scholar 

  109. Levin VA, Wilson CB, Davis R, Wara WM, Pischer TL, Irwin L (1979) A phase III comparison of BCNU, hydroxyurea and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas. J Neurosurg 51: 526–532

    PubMed  CAS  Google Scholar 

  110. Levin VA, Edwards MS, Wright DC, Seager ML, Schimberg TP, Townsend JJ, Wilson CB (1980) Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep 64: 237241

    Google Scholar 

  111. Levin VA, Hoffman WF, Heilbron DC, Norman D (1980) Prognostic significance of the pretreatment CT scan on time to progression for patients with malignant gliomas. J Neurosurg 52: 642–647

    PubMed  CAS  Google Scholar 

  112. Levin VA, Vestnys PS, Edwards MS, Wara WM, Fulton D, Barger G, Seager M. Wilson CB (1983) Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma. Cancer 51: 1364–1370

    CAS  Google Scholar 

  113. Levin VA, Edwards MSB, Gutin PH, Vestnys P, Fulton D, Seager ML, Wilson CB (1984) Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma. J Neurosurg 61: 1063–1068

    PubMed  CAS  Google Scholar 

  114. Levin VA (1985) Chemotherapy of primary brain tumors. Neurol Clin 3: 855–866

    PubMed  CAS  Google Scholar 

  115. Levin VA (1985) Chemotherapy of primary brain tumors. Neurol Clin 3: 855–866

    PubMed  CAS  Google Scholar 

  116. Levin VA, Wara WM, Davis RL, Vestnys P, Resser KJ, Yatsko K, Nutik S, Gutin PH, Wilson CB (1985) Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. J Neurosurg 63: 218–223

    Google Scholar 

  117. Loeffler JS, Ervin TJ, Mauch P, Skarin A, Weinstein HJ, Canellos G, Cassady JR (1985) Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 3: 490–494

    PubMed  CAS  Google Scholar 

  118. Mackintosh FR, Colby TV, Podolsky WJ, Burke JS, Hoppe RT, Rosenfelt FP, Rosenberg SA, Kaplan HS (1982) Central nervous system involvement in non-Hodgkin’s lymphoma: An analysis of 105 cases. Cancer 49: 586–595

    PubMed  CAS  Google Scholar 

  119. Mahaley MS jr, Urso MB, Whaley RA, Blue M, Williams TE, Guaspari A, Selker RG (1985) Immunobiology of primary intracranial tumors. J Neurosurg 63: 719–725

    PubMed  Google Scholar 

  120. Mahaley MS (1986) Neuro-oncology review: Radiotherapy, chemotherapy, immunotherapy. ( Unpublished manuscript )

    Google Scholar 

  121. Maral J, Poisson M, Pertuiset BF, Mashaly P, Weil M, Jacquillat C, Grillo-Lopez AJ (1985) Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human glioma. J Neuro-Oncol 3: 245–249

    Google Scholar 

  122. Markesbery WR, Brooks WH, Gupta GD, Young AB (1978) Treatment for patients with cerebral metastases. Arch Neurol 35: 754–756

    PubMed  CAS  Google Scholar 

  123. Marton LJ, et al. (1979) Predictive value of CSF polyamines. Cancer Res 39: 993–997

    PubMed  CAS  Google Scholar 

  124. Mazziotta JC (1985) PET scanning: principles and applications. Discussions in Neurosciences 2 /1

    Google Scholar 

  125. McKeran RO, Thomas DGT (1980) The clinical study of gliomas. In: Thomas DGT, Graham DI (eds) Brain tumours. Butterworths, London, pp 194–230

    Google Scholar 

  126. Mende S, Bleichner F, Stoeter P, Meuret G (1983) Erfolgreiche Behandlung von Hirnmetastasen bei Mammakarzinom mit nicht liquorgängigen Zytostatika and Hormonen. Onkologie 6: 58–61

    PubMed  CAS  Google Scholar 

  127. Mertens HG, Bogdahn U, Dommasch D, Krüger H, Wodarz R, Wünsch D (1983) Diagnostik and Therapie cerebrospinaler Manifestationen von Leukosen and malignen Lymphomen. In: Seitz D, Vogel P (Hrsg) Hämoblastosen, Zentrale Motorik, Iatrogene Schäden, Myositiden. Springer, Berlin Heidelberg New York. ( Verh Dt Ges Neur 2, S 49–69 )

    Google Scholar 

  128. Nagai M, Arai T, Kohno S, Kohase M (1980) Interferon therapy for malignant brain tumors. In: Kono R, Vilcek J (eds) The clinical potential of interferons. University of Tokyo Press, Tokyo, pp 257–273

    Google Scholar 

  129. Nagai M, Arai T (1984) Clinical effect of interferon in malignant brain tumours. Neurosurg Rev 7: 55–64

    PubMed  CAS  Google Scholar 

  130. Nagai M, Arai T (1985) Clinical studies on interferon therapy for malignant brain tumors—special reference to the effect of gamma-interferon. Abstracts ann meeting interferon system ( TNO/ISIR ), Clearwater Beach, p 147

    Google Scholar 

  131. Nakagawa Y, Hirakawa K, Ueda S, Suzuki K, Fukuma S, Kishida T, Imanishi J, Amagai T (1983) Local administration of interferon for malignant brain tumors. Cancer Treat Reports 67 /9: 833–835

    CAS  Google Scholar 

  132. Nakagawa Y (1984) Interferon therapy for primary brain tumors (Part I + II). Neurologia Medica-Chirurgica (Tokyo) 24: 83–89, 90–96

    Google Scholar 

  133. Neuwelt EA, Glasberg M, Frenkel E, Clark WK (1979) Malignant pineal region tumors. J Neurosurg 51: 597–607

    PubMed  CAS  Google Scholar 

  134. Neuwelt EA, Balaban E, Diehl J, Hill S, Frenkel E (1983) Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening. Neurosurgery 12: 662–671

    PubMed  CAS  Google Scholar 

  135. Newlands ES (1985) Chemotherapy for brain metastases. Prog Exp Tumor Res 29: 167–176

    PubMed  CAS  Google Scholar 

  136. Nishio S, Korosue K, Tateishi J, Fukui M, Kitamura K (1982) Ventricular and subarachnoid seeding of intracranial tumors of neuroectodermal origin—A study of 26 consecutive autopsy cases with reference to focal ependymal defect. Clin Neuropathol 1: 83–91

    PubMed  CAS  Google Scholar 

  137. Nishio S, Fukui M, Ohta M, Tateishi J, Kitamura K (1983) Spinal subarachnoid seeding from glioblastoma multiforme of the brain stem. Neurol Med Chir 23: 566–570

    CAS  Google Scholar 

  138. Obbens EAMT, Feun LG, Leavens ME, Savaraj N, Stewart DJ, Gutterman JU (1985) Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies. J Neuro-Oncol 3: 61–67

    CAS  Google Scholar 

  139. Ommaya AK (1963) Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet ii: 983–984

    Google Scholar 

  140. Otsuka S, Handa H, Yamashita J, Suda K, Takeuchi J (1984) Single agent therapy of interferon for brain tumours: Correlation between natural killer activity and clinical course. Acta Neurochirurgica 73: 13–23

    Google Scholar 

  141. Owens G, Javid R, Belmusto L, et al. (1965) Intra-arterial vincristine therapy of primary gliomas. Cancer 18: 756

    PubMed  CAS  Google Scholar 

  142. Paoletti P (1980) Therapeutic strategy for central nervous system tumors: Present status, criticism and potential. J Neurosurg SCI 28: 51–60

    Google Scholar 

  143. Paoletti P, Knerich R, Butti G, Adinolfi D, Locatelli D, Robustelli della Cuna G, Cordero di Montezemolo L, Schiffer D, Soffietti R, Nicolato A, Giunta F, Buoncristiani P, Scamoni C (1983) Italian cooperative study on malignant glial tumor therapy. In: Krauseneck P, Mertens HG (Hrsg) Therapie maligner Neoplasien des Gehirns. Perimed, Erlangen

    Google Scholar 

  144. Pasquier B, Pasquier D, N’golet A, Panh MH, Couderc P (1979) Le potentiel métastatique des tumeurs primitives du systeme nerveux central. Rev Neurol 135: 263278

    Google Scholar 

  145. Patronas NJ, di Chiro G, Brooks RA, et al (1982) Work in progress: (18F) Fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 144: 885–889

    PubMed  CAS  Google Scholar 

  146. Pierangeli E, Levin VA, Marton LJ (1983) Relationship of brain diffusion and capillary permeability of putrescine (Pu) to CSF levels in brain tumor patients. In: Krauseneck P, Mertens HG (Hrsg) Therapie maligner Neoplasien des Gehirns. Bërimed, Erlangen, S 151–153

    Google Scholar 

  147. Posner JB (1980) Chemotherapy and the nervous system. In: Ongerboer de Visser, Bosch DA, van Woerkom-Eykenboom WMH (eds) Neuro-oncology. M Nijhoff, Boston, pp 124–132

    Google Scholar 

  148. Posner JP (1982) Treatment of leptomeningeal metastases from solid tumors. In: Hildebrand J, Gangji D (eds) Treatment of neoplastic lesions of the nervous system. Pergamon Press, Oxford New York, pp 57–58

    Google Scholar 

  149. Pouillart P, Mathe G, Thy TH, Lheritier J, Poisson M, Huguenin P, Gauthier H, Morin P, Parrot R (1976) Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Cancer 38: 1909–1916

    PubMed  CAS  Google Scholar 

  150. Reuther P, Dommasch D, Fuhrmeister U, Krauseneck P, Mertens HG (1983) Intrathekale DTIC-Therapie bei leptomeningealer Melanommetastasierung. In: Krauseneck P, Mertens HG (Hrsg) Therapie maligner Neoplasien des Gehirns. Perimed, Erlangen, S 135–138

    Google Scholar 

  151. Rhodes CG, Wise RJS, Gibbs JM et al. (1983) In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann Neurol 14: 614–626

    PubMed  CAS  Google Scholar 

  152. Robustelli della Cuna G, Paoletti P, Bertolotti E, Knerich R, Bernardinelli L, Butti G, Baldi M (1979) Combined modality treatment of metastatic central nervous system (CNS) tumors with nitrosourea compounds. In: Paoletti P, Walker MD, Butti G, Knerich R (eds) Multidisciplinary aspects of brain tumor therapy. Elsevier, Amsterdam, pp 283–295

    Google Scholar 

  153. Rosen ST, Aisner J, Makuch RW, Matthews MJ, Ihde DC, Whitacre M,- Glatstein EJ, Wiernik PH, Lichter AS, Bunn PA jr (1982) Carcinomatous leptomeningitis in small cell lung cancer. Medicine 61: 45–53

    PubMed  CAS  Google Scholar 

  154. Rosenblum ML, Reynolds AF jr, Smith KA, Rumack BH, Walker MD (1973) Chloroethyl-cyclohexyl-nitrosourea ( CCNU) in the treatment of malignant brain tumors. J Neurosurg 39: 306–314

    Google Scholar 

  155. Rosner D, Nemoto T, Pickren J, Lane W (1983) Management of brain metastases from breast cancer by combination chemotherapy. J Neuro-Oncol 1/2: 131–1. 37

    Google Scholar 

  156. Rubinstein LJ (1975) The cerebellar medulloblastoma: its origin, differentiation, morphological variants and biological behavior. In: Vinken Pi, Bruyn GW (eds) Tumors of the brain and skull, part 3, vol 9. Elsevier/North-Holland Biomedical Press, New York, pp 167–194

    Google Scholar 

  157. Rustin GJS, Newlands ES, Bagshawe KD, Begent RHJ, Crawford SM (1986) Successful management of metastatic and primary germ cell tumors in the brain. Cancer 57: 2108–2113

    PubMed  CAS  Google Scholar 

  158. Safdari H, Boluix B, Gros C (1984) Multifocal brain radionecrosis masquerading as tumor dissemination. Surg Neurol 21: 35–41

    PubMed  CAS  Google Scholar 

  159. Sano K, Nagai M, Takakura K, Mogami H, Nomura K (1982) Effects of Hu IFN-ß on gliomas. Abstract, the third annual int congr for Interferon Research, Miami, Florida

    Google Scholar 

  160. Sapozink MD, Kaplan HS (1983) Intracranial Hodgkin’s disease. Cancer 52: 1301 1307

    Google Scholar 

  161. Schindler E (1985) Die Tumoren der Pinealisregion. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  162. Schmidt M, Krauseneck P, de l’Espine T, Kappos L (1982) Die Wertigkeit von Lungenfunktionsanalysen in der Diagnostik and Verlaufskontrolle von Zytostatika induzierten interstitiellen Pneumonien. Verhandl Dtsch Ges Inn Med 88: 438–441

    Google Scholar 

  163. Schöck LV (1983) Hochdosierte intralumbale Methotrexatgaben. Klinischer Erfahrungsbericht. Onkologie 6 /3: 109–112

    PubMed  Google Scholar 

  164. Schold SC jr, Friedman HS, Bjornsson TD, Folletta JM (1984) Treatment of patients with recurrent primary brain tumors with AZQ. Neurology 34: 615–619

    PubMed  Google Scholar 

  165. Seiler RW (1982) Die undifferenzierten Astrozytome des Großhirns. Springer, Berlin Heidelberg New York

    Google Scholar 

  166. Shapiro WR (1977) High-dose methotrexate in malignant gliomas. Cancer Treat Rep 61: 753–756

    PubMed  CAS  Google Scholar 

  167. Shapiro WR (1980) Chemotherapy of metastatic central nervous system carcinoma. In: Weiss L, Gilbert HA, Posner JB (eds) Brain metastasis. Hall, Boston, pp 328–339

    Google Scholar 

  168. Shapiro WR (1986) Therapy of adult malignant brain tumors: What have the clinical trials taught us? Semin Oncol 13: 38–45

    PubMed  CAS  Google Scholar 

  169. Sklansky BD, Mann-Kaplan RS, Reynolds AF jr, Rosenblum ML, Walker MD (1974) 4’-demethyl-epipodophyllotoxin-B-D-thenylidene-glucoside ( PTG) in the treatment of malignant intracranial neoplasms. Cancer 33: 460–467

    Google Scholar 

  170. Sorensen SC, Eagan RT, Scott M (1984) Meningeal carcinomatosis in patients with primary breast and lung cancer. Mayo Clin Proc 59: 91–94

    PubMed  CAS  Google Scholar 

  171. Stavrou D, Mellert W, Bilzer T, Senekowitsch R, Keiditsch E, Mehraein P (1985) Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data. Anticancer Res 5: 147–156

    Google Scholar 

  172. Stewart DJ, Russell N, Atack EA, Quarrington A, Stolbach L (1983) Cyclophosphamide, doxorubicin, vincristine, and dexamethasone in primary lymphoma of the brain: A case report. Cancer Treat Rep 67: 287–291

    Google Scholar 

  173. Stewart DJ, O’Bryan RM, Al-Sarraf M, Costanzi JJ, Oishi N (1983) Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study. J Neuro-Oncol 1: 145–147

    Google Scholar 

  174. Stewart DJ, Richard MT, Benoit B, Hugenholtz H, Russell N, Dennery J, Peterson E, Grahovac Z, Belanger A, Aitkens S, Young V, Maroun JA (1984) Cisplatin plus cytosine arabinoside in adults with malignant gliomas. J Neuro-Oncol 2: 29–34

    CAS  Google Scholar 

  175. Takakura K, Sano K, Hojo S, Hirano A (1982) Metastatic tumors of the central nervous system. Igaku-Shoin, Tokyo New York

    Google Scholar 

  176. Takakura K (1985) Phase II study of recombinant human interferon alpha A (RO 228181) for malignant brain tumors. Abstracts 14th int congr chemotherapy, Kyoto, p 353

    Google Scholar 

  177. Takakura K (1985) Intracranial germ cell tumors. Clin Neurosurg 32: 429–444

    PubMed  CAS  Google Scholar 

  178. Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozumi T, Matsutani M, Nomura K (1986) Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64: 5357

    Google Scholar 

  179. Talamo TS, Mendelow H (1985) Primary intracranial germinoma with massive ventriculoperitoneal shunt metastases. J Surg Oncol 28: 39–41

    PubMed  CAS  Google Scholar 

  180. Taylor SG IV, Nelson L, Baxter D, Rosenbaum C, Sponzo RW, Cunningham TJ, Olson KB, Horton J (1975) Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441). Cancer 36: 12691276

    Google Scholar 

  181. Theodore WH, Gendelman S (1981) Meningeal carcinomatosis. Arch Neurol 38: 696699

    Google Scholar 

  182. Tirelli U, d’Incalci M, Canetta R, Tumolo S, Franchin G, Veronesi A, Galligioni E, Trovo MG, Rossi C, Grigoletto E (1984) Etoposide (VP-16–213) in malignant brain tumors. A phase II study. J Clin Oncol 2: 432–437

    Google Scholar 

  183. Tranum BL, Haut A, Rivkin S, Weber E, Quagliana JM, Shaw M, Tucker WG, Smith FE, Samson M, Gottlieb J (1975) A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: A southwest oncology group study. Cancer 35: 11481153

    Google Scholar 

  184. Voth D, Hüwel N, Al-Hami S, Kuhnert A (1985) Monotreatment of malignant glioma with a derivate of nitrosourea, ACNU (first results). In: Voth D, Krauseneck P (eds) Chemotherapy of gliomas. De Gruyter, Berlin New York, pp 361–372

    Google Scholar 

  185. Vaquero J, Martinez R, Rossi E, Lopez R (1984) Primary cerebral lymphoma: the “ghost tumor”. J Neurosurg 60: 174–176

    PubMed  CAS  Google Scholar 

  186. Walker MD, Alexander E jr, Hunt WE, Leventhal CM, Mahaley MS jr, Mealey J jr, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA (1976) Evaluation of mithramycin in the treatment of anaplastic gliomas. J Neurosurg 44: 655–667

    PubMed  CAS  Google Scholar 

  187. Walker MD, Alexander E jr, Hunt WE, MacCarty CS, Mahaley MS jr, Mealey J jr, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49: 333–343

    PubMed  CAS  Google Scholar 

  188. Walker MD, Green SB, Byar DP, Alexander E jr, Batzdorf U, Brook WH, Hunt WE, MacCarty CS, Mahaley MS jr, Mealey J jr, Owens G, Ransohoff J II, Robertson JT, Shapiro WR, Smith KR jr, Wilson CB, Strike TA (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N England J Med 303: 1323–1329

    CAS  Google Scholar 

  189. Wasserstrom WR, Glass PJ, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients. Cancer 49: 759–772

    PubMed  CAS  Google Scholar 

  190. Wilson CB, Boldrey EB, Enot KJ (1970) 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC409962) in the treatment of brain tumors. Cancer Chemo Rep 54/4: 273–281

    Google Scholar 

  191. Yap HY, Yap BS, Rasmussen S, Levens M, Hortobagyi GN, Blumenschein GR (1982) Treatment for meningeal carcinomatosis in breast cancer. Cancer 49: 219–222

    Google Scholar 

  192. Young RC, Waler MD, Canellos GP, Schein PS, Chabner BA, DeVita VT (1973) Initial clinical trials with methyl-CCNU 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1 - nitrosourea ( MeCCNU ). Cancer 31: 1164–1169

    Google Scholar 

  193. Zülch KJ (1979) Histological typing of tumours of the central nervous system. WHO, Genf

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Würzburg, Federal Republic of Germany

    Prof. Dr. Dipl.-Psych. P. Krauseneck & H. G. Mertens

Authors
  1. Prof. Dr. Dipl.-Psych. P. Krauseneck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. G. Mertens
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Ludwig Boltzmann Institute of Clinical Neurobiology, Lainz Hospital, Vienna, Austria

    Kurt Jellinger

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag/Wien

About this chapter

Cite this chapter

Krauseneck, P., Mertens, H.G. (1987). Results of Chemotherapy of Malignant Brain Tumors in Adults. In: Jellinger, K. (eds) Therapy of Malignant Brain Tumors. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8876-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-8876-7_7

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-8878-1

  • Online ISBN: 978-3-7091-8876-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation